• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Biomedical and Pharmaceutical Sciences
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 8 (2025)
Volume Volume 7 (2024)
Volume Volume 6 (2023)
Volume Volume 5 (2022)
Volume Volume 4 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 3 (2020)
Volume Volume 2 (2019)
Volume Volume 1 (2018)
Samir, M., Ramadan, M., Hamed, M., Osman, M., Abou=Rahma, G. (2021). Recent Strategies in Design of Antitumor and Antibacterial Fluoroquinolones. Journal of Advanced Biomedical and Pharmaceutical Sciences, 4(3), 134-151. doi: 10.21608/jabps.2021.68305.1124
Mohamed Samir; Mohammed Ramadan; Mostafa Hamed; Mohamed Osman; Gamal Abou=Rahma. "Recent Strategies in Design of Antitumor and Antibacterial Fluoroquinolones". Journal of Advanced Biomedical and Pharmaceutical Sciences, 4, 3, 2021, 134-151. doi: 10.21608/jabps.2021.68305.1124
Samir, M., Ramadan, M., Hamed, M., Osman, M., Abou=Rahma, G. (2021). 'Recent Strategies in Design of Antitumor and Antibacterial Fluoroquinolones', Journal of Advanced Biomedical and Pharmaceutical Sciences, 4(3), pp. 134-151. doi: 10.21608/jabps.2021.68305.1124
Samir, M., Ramadan, M., Hamed, M., Osman, M., Abou=Rahma, G. Recent Strategies in Design of Antitumor and Antibacterial Fluoroquinolones. Journal of Advanced Biomedical and Pharmaceutical Sciences, 2021; 4(3): 134-151. doi: 10.21608/jabps.2021.68305.1124

Recent Strategies in Design of Antitumor and Antibacterial Fluoroquinolones

Article 3, Volume 4, Issue 3, July 2021, Page 134-151  XML PDF (1.55 MB)
Document Type: Review Articles
DOI: 10.21608/jabps.2021.68305.1124
View on SCiNiTO View on SCiNiTO
Authors
Mohamed Samir1; Mohammed Ramadan2; Mostafa Hamed2; Mohamed Osman3; Gamal Abou=Rahma email 4
1Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Al-Azhar University, 71524 Assiut
2Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Al-Azhar University, 71524 Assiut, Egypt
3Medicinal Chemistry Department, Faculty of Pharmacy, Minia University.
4Medicinal Chemistry Department, Faculty of Pharmacy, Minia University
Abstract
Fluoroquinolones are known widely used synthetic antibacterial agents. Generally, there were some obstacles associated with their therapeutic use. Moreover, many research studies all over the world proved the variable biological effects of fluoroquinolones such as antituberculosis, anticancer, or even antiviral activities. The current review is focused on modifications that occurred in the fluoroquinolone scaffold for their repositioning from antibacterial into anticancer agents especially modifications at C-7 or at the carboxylic C-3 groups. In addition, it includes the recent research studies carried out to improve the potency, spectrum of activity, or pharmacokinetics of antibacterial fluoroquinolones. Hence, this review may be useful for researchers in the design and synthesis of new fluoroquinolones with improved biological activities.
Keywords
Fluoroquinolones; Antitumor; Antibacterial; Design
Main Subjects
Analytical and Medicinal Chemistry
Statistics
Article View: 705
PDF Download: 1,427
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.